2026 World Vaccine Congress Roundtable

Efforts to improve clinical trial access and representation have expanded significantly in recent years, yet participation gaps persist. The discussion highlights how trust, community influence, and patient experience are increasingly shaping trial participation. It also underscores the need to move beyond treating communication as a downstream activity and instead embed it into trial design, engagement strategies, and stakeholder alignment from the outset.

This executive summary captures insights from the 2026 World Vaccine Congress Roundtable, featuring experts from Novavax, EmVenio Clinical Research, GSK, Precision for Medicine, and Veristat.

Access the full summary by filling out the form below.